Brain region–specific action of ketamine as a rapid antidepressant
Science · 09.08.2024 · 385 (6709)
DOI: 10.1126/science.ado7010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 09.08.2024. Verfasst von Min Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Affiliated Mental Health Center & Hangzhou Seventh People's Hospital and School of Brain Science and Brain Medicine, Zhejiang Universit…. Hauptthemen laut MEDLINE: Antidepressive Agents, Depression, Habenula, Ketamine. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Ketamine has been found to have rapid and potent antidepressant activity. However, despite the ubiquitous brain expression of its molecular target, the N -methyl- d -aspartate receptor (NMDAR), it was not clear whether there is a selective, primary site for ketamine’s antidepressant action. We found that ketamine injection in depressive-like mice specifically blocks NMDARs in lateral habenular (LHb) neurons, but not in hippocampal pyramidal neurons. This regional specificity depended on the use-dependent nature of ketamine as a channel blocker, local neural activity, and the extrasynaptic reservoir pool size of NMDARs. Activating hippocampal or inactivating LHb neurons swapped their ketamine sensitivity. Conditional knockout of NMDARs in the LHb occluded ketamine’s antidepressant effects and blocked the systemic ketamine–induced elevation of serotonin and brain-derived neurotrophic factor in the hippocampus. This distinction of the primary versus secondary brain target(s) of ketamine should help with the design of more precise and efficient antidepressant treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Affiliated Mental Health Center & Hangzhou Seventh People's Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China.
- Liangzhu Laboratory, MOE Frontier Science Center for Brain Science and Brain-Machine Integration, State Key Laboratory of Brain-Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou 311…
- The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University School of Medicine, Zhejiang University, Yiwu 322000, China.
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai 200433, China.
- State Key Laboratory of Membrane Biology, New Cornerstone Science Laboratory, School of Life Sciences, Peking University, Beijing 100871, China.
- Key Laboratory of Brain Functional Genomics, Ministry of Education, Shanghai Key Laboratory of Brain Functional Genomics, School of Life Science, East China Normal University, Shanghai 200062, China.
ORCID-Profile: Min Chen, Yiyan Dong, Jingxiang Tang, Hefeng Huang, Yulong Li, Hailan Hu
Förderung
- NIGMS NIH HHS
Zitieren
APA
Chen, M., Ma, S., Liu, H., Dong, Y., Tang, J., Ni, Z., Tan, Y., Duan, C., Li, H., Huang, H., Li, Y., Cao, X., Lingle, C. J., Yang, Y., & Hu, H. (2024). Brain region–specific action of ketamine as a rapid antidepressant. Science, 385(6709). https://doi.org/10.1126/science.ado7010
Vancouver
Chen M, Ma S, Liu H, Dong Y, Tang J, Ni Z, et al. Brain region–specific action of ketamine as a rapid antidepressant. Science. 2024;385(6709). doi:10.1126/science.ado7010
BibTeX
@article{Chen2024,
author = {Chen, Min and Ma, Shuangshuang and Liu, Hanxiao and Dong, Yiyan and Tang, Jingxiang and Ni, Zheyi and Tan, Yi and Duan, Chenchi and Li, Hui and Huang, Hefeng and Li, Yulong and Cao, Xiaohua and Lingle, Christopher J and Yang, Yan and Hu, Hailan},
title = {Brain region–specific action of ketamine as a rapid antidepressant},
journal = {Science},
year = {2024},
volume = {385},
number = {6709},
doi = {10.1126/science.ado7010}
}
EUVIMED